메뉴 건너뛰기




Volumn 16, Issue 4-5, 1998, Pages 265-274

Economic evaluation of hematopoietic growth factor using French DRG data;Utilisation du PMSI pour l'evaluation economique des facteurs de croissance hematopoietiques

Author keywords

Breast Cancer; Chemotherapy; Cost effectiveness analysis; Hematopoietic growth factor

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR;

EID: 0032408176     PISSN: 02940736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (14)
  • 1
    • 0026344803 scopus 로고
    • Dose intensity as a therapeutic strategy in breast cancer
    • Osborne CK. Dose intensity as a therapeutic strategy in breast cancer. Breast Cancer Res Treat 1991;20:S11-S14.
    • (1991) Breast Cancer Res Treat , vol.20
    • Osborne, C.K.1
  • 2
    • 0029187792 scopus 로고
    • High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer : Yes
    • Philadelphia : Lippincott Company.
    • Peters WP. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer : Yes. In : Important advances in oncology 1995. Philadelphia : Lippincott Company. 1995: 215-230.
    • (1995) Important Advances in Oncology 1995 , pp. 215-230
    • Peters, W.P.1
  • 3
    • 13044254000 scopus 로고
    • L'évaluation des facteurs de croissance hématopoïétiques (FCH) : De la minimisation des coûts à une véritable analyse économique
    • Le Corroller AG, Moatti JP, Detournay B, Fagnani F, Biaise D, Maraninchi D. L'évaluation des facteurs de croissance hématopoïétiques (FCH) : de la minimisation des coûts à une véritable analyse économique. Cah Oncol 1993;2:267-273.
    • (1993) Cah Oncol , vol.2 , pp. 267-273
    • Le Corroller, A.G.1    Moatti, J.P.2    Detournay, B.3    Fagnani, F.4    Biaise, D.5    Maraninchi, D.6
  • 4
    • 0344834092 scopus 로고
    • Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation
    • Sheridan WP, Morstyn G, Wolf M et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989;2:891-5.
    • (1989) Lancet , vol.2 , pp. 891-895
    • Sheridan, W.P.1    Morstyn, G.2    Wolf, M.3
  • 5
    • 0027019408 scopus 로고
    • Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor
    • Schwartzberg LS, Birch R, Hazelton B, Tauer KW, Lee P, Altemose R et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematotherapy 1992;1:317-327.
    • (1992) J Hematotherapy , vol.1 , pp. 317-327
    • Schwartzberg, L.S.1    Birch, R.2    Hazelton, B.3    Tauer, K.W.4    Lee, P.5    Altemose, R.6
  • 6
    • 0028255992 scopus 로고
    • Randomized study of growth factors post-peripheral-blood stem-cell transplant : Neutrophil recovery is improved with modest clinical benefit
    • Spitzer G, Adkins DR, Spencer V, et al. Randomized study of growth factors post-peripheral-blood stem-cell transplant : neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 1994; 12:661-670.
    • (1994) J Clin Oncol , vol.12 , pp. 661-670
    • Spitzer, G.1    Adkins, D.R.2    Spencer, V.3
  • 8
    • 0026504705 scopus 로고
    • Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
    • Sheridan WP, Begley CG, Juttner CA, Szer J, Bik To L, Maher D et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. The Lancet 1992;339:640-644.
    • (1992) The Lancet , vol.339 , pp. 640-644
    • Sheridan, W.P.1    Begley, C.G.2    Juttner, C.A.3    Szer, J.4    Bik To, L.5    Maher, D.6
  • 9
    • 0027413697 scopus 로고
    • Comparative effects of granulocytemacrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating Factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy
    • Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C et al. Comparative effects of granulocytemacrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating Factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993;817:1709-1719.
    • (1993) Blood , vol.817 , pp. 1709-1719
    • Peters, W.P.1    Rosner, G.2    Ross, M.3    Vredenburgh, J.4    Meisenberg, B.5    Gilbert, C.6
  • 10
    • 0029875452 scopus 로고    scopus 로고
    • The clinical effectiveness and financial impact of utilizing peripheral blood progenitor cell as rescue therapy following autologous bone marrow transplant
    • Kucharski AJ, Ghalie R, Greenstein S, Matuszewki K. The clinical effectiveness and financial impact of utilizing peripheral blood progenitor cell as rescue therapy following autologous bone marrow transplant. International Journal of Technology Assessment in Health Care 1996;72;1: 172-179.
    • (1996) International Journal of Technology Assessment in Health Care , vol.72 , Issue.1 , pp. 172-179
    • Kucharski, A.J.1    Ghalie, R.2    Greenstein, S.3    Matuszewki, K.4
  • 11
    • 0027953956 scopus 로고
    • L'évaluation économique du G-CSF en thérapeutique cancérologique : Deux études françaises
    • Le Corroller AG, Moatti JP, Detournay B, Fagnani F, Biaise D et al. L'évaluation économique du G-CSF en thérapeutique cancérologique : deux études françaises. La Presse Médicale 1994;23;24:1105-1109.
    • (1994) La Presse Médicale , vol.23 , Issue.24 , pp. 1105-1109
    • Le Corroller, A.G.1    Moatti, J.P.2    Detournay, B.3    Fagnani, F.4    Biaise, D.5
  • 12
    • 0027538580 scopus 로고
    • Pharmacoeconomic issues in the use of granulocyte-macrophage colony-stimulating factor for bone marrow transplantation or chemotherapy-induced neutropenia
    • Weber RJ. Pharmacoeconomic issues in the use of granulocyte-macrophage colony-stimulating factor for bone marrow transplantation or chemotherapy-induced neutropenia. Clinical Therapeutics 1993;75; 1:180-191.
    • (1993) Clinical Therapeutics , vol.75 , Issue.1 , pp. 180-191
    • Weber, R.J.1
  • 13
    • 13044262294 scopus 로고    scopus 로고
    • Analyse médico-économique de l'activité hospitalière
    • Ministère du Travail et des Affaires Sociales Numéro spécial - mai
    • Le PMSI. Analyse médico-économique de l'activité hospitalière. Ministère du Travail et des Affaires Sociales. La lettre d'Informations hospitalières - Numéro spécial - mai 1996.
    • (1996) La Lettre d'Informations Hospitalières
    • Le, P.M.S.I.1
  • 14
    • 84876138133 scopus 로고    scopus 로고
    • Fascicule spécial no 95-5 bis
    • Echelle Nationale de Coûts Relatifs par Groupe Homogène de Malade 1995. Bulletin Officiel. Fascicule spécial no 95-5 bis.
    • Bulletin Officiel


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.